|
|
|
|
|
文献清单:2025年封面文章 | MDPI Biomedicines |
|
|
期刊名:Biomedicines
期刊主页:https://www.mdpi.com/journal/biomedicines
本期文献清单为您汇总Biomedicines期刊2025年的12篇封面文章,助您快速掌握前沿进展,拓展科研思路。
1. Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function
Bcl-2 与 Bcl-xL 在糖尿病中的作用:对内分泌胰腺存活与功能的贡献
https://www.mdpi.com/2227-9059/13/1/223
Perez-Serna, A.A.; Guzman-Llorens, D.; Dos Santos, R.S.; Marroqui, L. Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function. Biomedicines 2025, 13, 223. https://doi.org/10.3390/biomedicines13010223

2. Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases
炎症性肠病发病机制的新见解
https://www.mdpi.com/2227-9059/13/2/305
Calvez, V.; Puca, P.; Di Vincenzo, F.; Del Gaudio, A.; Bartocci, B.; Murgiano, M.; Iaccarino, J.; Parand, E.; Napolitano, D.; Pugliese, D.; et al. Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases. Biomedicines 2025, 13, 305. https://doi.org/10.3390/biomedicines13020305

3.Autoantibodies Against Factor B and Factor H Without Pathogenic Effects in a Patient with Immune Complex-Mediated Membranoproliferative Glomerulonephritis
免疫复合物介导的膜增生性肾小球肾炎患者抗因子B和因子H的自身抗体无致病作用
https://www.mdpi.com/2227-9059/13/3/648
Matola, A.T.; Csuka, D.; Szilágyi, Á.; Rudnicki, M.; Prohászka, Z.; Józsi, M.; Uzonyi, B. Autoantibodies Against Factor B and Factor H Without Pathogenic Effects in a Patient with Immune Complex-Mediated Membranoproliferative Glomerulonephritis. Biomedicines 2025, 13, 648. https://doi.org/10.3390/biomedicines13030648

4. Electroacupuncture Attenuates Intestinal Barrier Disruption via the α7nAChR-Mediated HO-1/p38 MAPK/NF-κB Pathway in a Mouse Model of Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized, Single-Blind, Controlled Trial
电针通过α7nAChR介导的HO-1/p38 MAPK/NF-κB通路减轻代谢功能障碍相关脂肪性肝病小鼠的肠道屏障损伤:一项随机、单盲、对照试验
https://www.mdpi.com/2227-9059/13/4/802
Wang, X.; Sun, J.; Wang, P.; Zhang, Y.; Chang, J.; Duan, Z. Electroacupuncture Attenuates Intestinal Barrier Disruption via the α7nAChR-Mediated HO-1/p38 MAPK/NF-κB Pathway in a Mouse Model of Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized, Single-Blind, Controlled Trial. Biomedicines 2025, 13, 802. https://doi.org/10.3390/biomedicines13040802

5. Photobiomodulation in Medication-Related Osteonecrosis of the Jaw: Outcomes in Stage I and Its Adjunctive Role in Advanced Cases
光生物调节在药物相关性颌骨坏死中的应用:I期的结果及其在晚期病例中的辅助作用
https://www.mdpi.com/2227-9059/13/5/1042
Michalak, F.; Dominiak, M.; Grzech-Lesniak, Z.; Kiryk, J.; Grzech-Lesniak, K. Photobiomodulation in Medication-Related Osteonecrosis of the Jaw: Outcomes in Stage I and Its Adjunctive Role in Advanced Cases. Biomedicines 2025, 13, 1042. https://doi.org/10.3390/biomedicines13051042

6. Atherosclerosis and Insulin Resistance: Is There a Link Between Them?
动脉粥样硬化和胰岛素抵抗:两者之间有联系吗
https://www.mdpi.com/2227-9059/13/6/1291
Brie, A.D.; Christodorescu, R.M.; Popescu, R.; Adam, O.; Tîrziu, A.; Brie, D.M. Atherosclerosis and Insulin Resistance: Is There a Link Between Them? Biomedicines 2025, 13, 1291. https://doi.org/10.3390/biomedicines13061291

7. JAK2 Inhibitors and Emerging Therapies in Graft-Versus-Host Disease: Current Perspectives and Future Directions
移植抗宿主病的JAK2抑制剂和新疗法:当前视角与未来方向
https://www.mdpi.com/2227-9059/13/7/1527
Amoozgar, B.; Bangolo, A.; Mohamed, A.; Mansour, C.; Elias, D.; Cho, C.; Reddy, S. JAK2 Inhibitors and Emerging Therapies in Graft-Versus-Host Disease: Current Perspectives and Future Directions. Biomedicines 2025, 13, 1527. https://doi.org/10.3390/biomedicines13071527

8. Is TGF-β Associated with Cytokines and Other Biochemical or Clinical Risk Parameters in Early-Onset CAD Patients?
TGF-β是否与早发性冠心病患者的细胞因子及其他生化或临床风险参数相关?
https://www.mdpi.com/2227-9059/13/8/1840
Rakoczy, B.; Dziedziejko, V.; Safranow, K.; Rac, M. Is TGF-β Associated with Cytokines and Other Biochemical or Clinical Risk Parameters in Early-Onset CAD Patients? Biomedicines 2025, 13, 1840. https://doi.org/10.3390/biomedicines13081840

9. Molecular Mechanisms of Iron Metabolism and Overload
铁代谢和超载的分子机制
https://www.mdpi.com/2227-9059/13/9/2067
Tayal, A.; Kaur, J.; Sadeghi, P.; Maitta, R.W. Molecular Mechanisms of Iron Metabolism and Overload. Biomedicines 2025, 13, 2067. https://doi.org/10.3390/biomedicines13092067

10. Decoding Early Clues: Immune Mechanisms, Prevention, Diagnosis, and Treatment of IgE-Mediated Peanut and Tree Nut Allergy in Children
解码早期线索:儿童IgE介导的花生和树坚果过敏的免疫机制、预防、诊断与治疗
https://www.mdpi.com/2227-9059/13/10/2377
Dumycz, K.; Szczukocka, A.; Wawszczak, M.; Grzela, K.; Feleszko, W.; Kulus, M. Decoding Early Clues: Immune Mechanisms, Prevention, Diagnosis, and Treatment of IgE-Mediated Peanut and Tree Nut Allergy in Children. Biomedicines 2025, 13, 2377. https://doi.org/10.3390/biomedicines13102377

11. The Role of mTOR Signaling in Tumor-Induced Alterations to Neuronal Function in Diffusely Infiltrating Glioma
mTOR信号通路在弥漫浸润性胶质瘤引起神经元功能改变中的作用
https://www.mdpi.com/2227-9059/13/11/2593
Haile, H.; Leskinen, S.; Adapa, A.R.; R. Goldberg, A.; Viswanathan, A.; Milligan, C.; Conboy, K.; Schevon, C.; Canoll, P.; Gill, B.J.A. The Role of mTOR Signaling in Tumor-Induced Alterations to Neuronal Function in Diffusely Infiltrating Glioma. Biomedicines 2025, 13, 2593. https://doi.org/10.3390/biomedicines13112593

12. Galanthamine Fails to Reverse P-gp-Mediated Paclitaxel Resistance in Ovarian Cancer Cell Lines
加兰他敏不能逆转P-gp介导的卵巢癌细胞系紫杉醇耐药性
https://www.mdpi.com/2227-9059/13/12/2852
Fonseca, N.; Nunes, M.; Silva, P.M.A.; Bousbaa, H.; Ricardo, S. Galanthamine Fails to Reverse P-gp-Mediated Paclitaxel Resistance in Ovarian Cancer Cell Lines. Biomedicines 2025, 13, 2852. https://doi.org/10.3390/biomedicines13122852

Biomedicines 期刊介绍
主编: Felipe Fregni, Harvard Medical School, USA
期刊主题涵盖人类健康和疾病的所有方面,如疾病的发病机制、转化医学、纳米医学、临床研究、基因疗法、细胞疗法、靶向治疗、生物制品、生物医学研究中的生物材料、天然生物活性分子、疫苗、靶向特异性抗体、重组治疗蛋白、生物成像、生物传感器、生物标志物、生物仿制药和纳米生物仿制药等。目前期刊已被 SCIE、Scopus、PubMed 和 OAJ 等数据库收录。
2024 Impact Factor:3.9 (Q1)
2024 CiteScore:6.8 (Q1)
Time to First Decision:21 Days
Acceptance to Publication:2.8 Days
特别声明:本文转载仅仅是出于传播信息的需要,并不意味着代表本网站观点或证实其内容的真实性;如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任;作者如果不希望被转载或者联系转载稿费等事宜,请与我们接洽。